Effectiveness of Plasma Treatment on Pancreatic Cancer Cells
Four pancreatic cancer cell lines were used and the antitumor effects of plasma-activated medium treatment were evaluated using a cell proliferation assay. To explore functional mechanisms, morphological change and caspase-3/7 activation in cells were also assessed. [Int J Oncol] Abstract

Filamin A: Insights into Its Exact Role in Cancers
The authors give a comprehensive summary of filamin A (FlnA)’s expression in cancers. Where available, they also indicate the correlation of FlnA with cancer stages and patient prognosis, and clarify its localization and its dual role in different cancers. [Pathol Oncol Res] Abstract

Visit our reviews page to see a complete list of reviews in the pancreatic cell research field.

SCIENCE NEWS

Merck to Present New Data at the European Cancer Congress 2015 Reinforcing the Company’s Patient-Centric Focus
Merck will present new data on early- and late-stage compounds from its refocused oncology and immuno-oncology pipeline, as well as Erbitux® (cetuximab) data. These data reinforce the company’s science-driven and patient-centric approach to developing new therapies that will help patients fight difficult-to-treat cancers such as pancreatic, non-small cell lung and urothelial. [Press release from Merck & Co., Inc. (CNW Group Ltd.) discussing research to be presented at the European Cancer Congress (ECC) 2015, Vienna] Press Release

First Transplant Patient in BioHub Trial No Longer Needs Insulin Therapy
Wendy Peacock, the first transplant recipient in the clinical trial being conducted by the Diabetes Research Institute of its BioHub — a bioengineered mini-organ containing islet cells that mimics the native pancreas to restore natural insulin production in people with type 1 diabetes — now has normal glucose levels and has been taken off the supplemental insulin that she gave herself by injection several times daily for the past 26 years. [University of Miami Health System] Press Release

Nearly $10 Million to Be Invested to Support Pancreatic Cancer Research
The Pancreatic Cancer Action Network announced it will invest nearly $9.7 million in research in 2016, representing a more than 40 percent increase over last year’s investment. The expanded grants program aims to advance progress toward patient benefit. Close to $6.8 million will be awarded through the organization’s competitive Research Grants Program. [Pancreatic Cancer Action Network (PR Newswire Association LLC)] Press Release

UChicago Medicine Earns Prestigious Pancreas Center Designation
The University of Chicago Medicine has been named a National Pancreas Foundation Center, one of only 30 facilities in the country to receive the prestigious designation from the health advocacy group. The National Pancreas Foundation (NPF) created the NPF Center designation in order to help patients find high-quality, multidisciplinary care. [University of Chicago Medicine] Press Release